Alpha-1 Antitrypsin Deficiency

Alpha-1 Antitrypsin Deficiency Adult Liver Study

A Phase 1/2a, Single- and Multiple-dose Escalation Study of KRRO-110

A Phase 1b/2a, Open-label Single Ascending Doses and Multiple Ascending Doses Study in Participants With Pi*ZZ AATD

Phase 4, Double-blind Study Evaluating the Response on Computed Tomography (CT) Lung Density Decline Rates of Respreeza / Zemaira Weekly for 3 Years in Adults With alpha1 Antitrypsin Deficiency (AATD)

A Study of ARC-AAT in Healthy Volunteer Subjects and Patients With Alpha-1 Antitrypsin Deficiency (AATD)

Safety, Tolerability and Effect of ARC-AAT Injection on Circulating and Intrahepatic Alpha-1 Antitrypsin Levels

The Alpha-1 Foundation's and University of Florida's Alpha-1 Coded Testing (ACT) Study

Lung Disease and Its Affect on the Work of White Blood Cells in the Lungs

A Study to Evaluate Efficacy and Safety of VX-864 in Participants With the PiZZ Genotype

Respreeza® Self-administration and Learning Program (AmAREtTI Study)

NTLA-3001 in Adults with Alpha-1 Antitrypsin Deficiency-Associated Lung Disease

Long-Term Follow-up Study of ADVM-043

FibroScan™ in Pediatric Cholestatic Liver Disease (FORCE)

COPD Exacerbation Blood and Urine Biomarkers Study

A Phase 1, First-in-human Study of VX-668

Liver Fibrosis in Alpha-1 Antitrypsin Deficiency (Liver AATD)

A Single Ascending and Repeated Dose Study of Oral ZF874 in Healthy Volunteers and PiXZ Subjects

Phase 1 Study to Assess the Safety, PK and PD of INBRX-101 in Adults With Alpha-1 Antitrypsin Deficiency

Targeting Pulmonary Perfusion in Alpha-1 Antitrypsin Deficiency

Phase II, Safety and Efficacy Study of Kamada-alpha-1-antitrypsin (AAT) for Inhalation"